Why the Exposure Metric Must Match the Mechanism
A concentration-time profile contains more information than any single summary can retain. Two regimens can have the same area under the curve (AUC) but different peaks and durations; two profiles can have the same maximum concentration but very different total exposure. The useful question is therefore not “Which metric is best?” but which feature of exposure is expected to drive the response being modeled?
This tutorial compares four summaries: maximum concentration, AUC, time above a potency threshold, and time-integrated target inhibition. The choice depends on the proposed pharmacology and the response pattern, not on which metric gives the strongest association in a particular data set. These metrics summarize exposure; none alone proves a mechanism or establishes that exposure caused a clinical response.
The units help clarify what each quantity represents. \(C_{\max}\) has units of concentration, AUC has units of concentration multiplied by time, and \(T_{>K}\) has units of time. If \(I(C)\) is a fraction from 0 to 1, then \(J_{0,T}\) also has units of time; it can be interpreted as the accumulated inhibition fraction over the interval. For example, inhibition of 0.5 sustained for 4 hours contributes 2 inhibition-hours.
Assumptions and Mechanistic Interpretation
A fair comparison requires that concentration profiles refer to the same analyte, the same relevant concentration compartment, and the same time window. If the target responds to unbound concentration at the target site, total plasma concentration may be a poor substitute. The profile must also be measured or estimated well enough to capture peaks and threshold crossings. For intermittent dosing, the interval should match the response question: one dosing interval may be appropriate for a repeating regimen, whereas a longer interval may be needed for a response that accumulates across doses.
For a simple reversible concentration-driven mechanism at equilibrium, a common model for fractional inhibition is:
Here \(IC_{50}\) is the concentration producing 50% inhibition under the specified assay or model conditions. This particular equation assumes a maximal fractional inhibition of 1, a Hill coefficient of 1, and an immediate equilibrium relation between concentration and inhibition. If the relevant inhibition model has a different maximal effect or Hill coefficient, use that model’s \(I(C)\) when calculating \(J_{0,T}\). A biochemical \(IC_{50}\) is not automatically a clinically effective threshold: potency can depend on assay conditions, substrate, cellular context, and target access.
The metrics correspond to different mechanistic hypotheses. \(C_{\max}\) can be informative when the response is driven by the strongest short-lived concentration, such as an acute effect that rises monotonically with instantaneous concentration. AUC is a useful overall exposure summary, but it predicts response only under a suitable exposure-response relationship; it is not a universal measure of effect. \(T_{>K}\) fits a threshold-duration hypothesis, in which time spent above a relevant concentration matters more than the height of a peak once the threshold is crossed. \(J_{0,T}\) is appropriate when the magnitude of inhibition and its duration both contribute to accumulated pharmacological pressure.
Why AUC and Integrated Inhibition Can Disagree
The distinction between AUC and integrated inhibition follows directly from the concentration-response curve. When \(C\) is much smaller than \(IC_{50}\), inhibition is approximately proportional to concentration:
In this low-concentration range, AUC and integrated inhibition may rank profiles similarly, assuming the same \(IC_{50}\) and interval. At concentrations much larger than \(IC_{50}\), inhibition approaches 1 and additional concentration produces little additional inhibition:
In that range, integrated inhibition is driven mainly by how long concentration remains high enough for near-maximal inhibition; AUC can keep increasing with concentration even when inhibition barely changes. This is one reason to calculate the metric that corresponds to the hypothesized biology rather than substituting AUC by habit.
Worked Example: Equal AUC, Different Peak and Duration
Consider two hypothetical unbound concentration profiles over a 5-hour interval. Profile A is 10 mg/L for 1 hour and then 0 mg/L for 4 hours. Profile B is 2 mg/L throughout the 5 hours. Suppose a rapid concentration-driven response increases monotonically with concentration, while a separate hypothesis proposes that sustained inhibition matters. Use \(K=1.5\) mg/L and \(IC_{50}=2\) mg/L.
For Profile A, \(C_{\max}=10\) mg/L and \(AUC_{0,5}=(10\text{ mg/L})(1\text{ h})=10\) mg·h/L. For Profile B, \(C_{\max}=2\) mg/L and \(AUC_{0,5}=(2\text{ mg/L})(5\text{ h})=10\) mg·h/L. Thus AUC is equal, but the peak is five times higher for Profile A.
Both profiles exceed \(K=1.5\) mg/L only while their stated nonzero concentrations are present. Therefore, \(T_{>K}=1\) hour for Profile A and \(T_{>K}=5\) hours for Profile B.
For Profile A, \(J_{0,5}=(10/(2+10))(1\text{ h})=0.8333\) inhibition-hours. For Profile B, \(J_{0,5}=(2/(2+2))(5\text{ h})=2.500\) inhibition-hours. Under a monotone, immediate concentration-response model, Profile A has the stronger peak effect; under a cumulative-inhibition hypothesis, Profile B has the greater integrated inhibition. Equal AUC does not settle which response pattern is more relevant.
Worked Example: Same Peak, Different Exposure Duration
Suppose two hypothetical profiles are observed over 4 hours. Profile A is 8 mg/L for 0.5 hour, then 0 mg/L for 3.5 hours. Profile B is 8 mg/L for 0.5 hour, then 4 mg/L for 3.5 hours. Let the threshold be \(K=2\) mg/L and \(IC_{50}=4\) mg/L.
Both profiles have \(C_{\max}=8\) mg/L. Their AUCs differ: Profile A has \(AUC_{0,4}=(8)(0.5)=4\) mg·h/L, while Profile B has \(AUC_{0,4}=(8)(0.5)+(4)(3.5)=4+14=18\) mg·h/L.
For Profile A, concentration exceeds 2 mg/L for 0.5 hour, so \(T_{>K}=0.5\) hour. Profile B remains above 2 mg/L for the full 4 hours, so \(T_{>K}=4\) hours.
At 8 mg/L, \(I(8)=8/(4+8)=0.6667\); at 4 mg/L, \(I(4)=4/(4+4)=0.5000\). Thus Profile A has \(J_{0,4}=(0.6667)(0.5)=0.3333\) inhibition-hours. Profile B has \(J_{0,4}=(0.6667)(0.5)+(0.5000)(3.5)=0.3333+1.750=2.083\) inhibition-hours. The common peak would not distinguish these profiles, whereas a sustained-response pattern would make their different duration and integrated inhibition important.
Worked Example: Same Time Above Threshold, Different Inhibition Depth
Now compare two hypothetical profiles that each remain constant for 2 hours and are zero for the rest of a 6-hour interval. Profile A is 4 mg/L during those 2 hours; Profile B is 8 mg/L. Use \(K=2\) mg/L and \(IC_{50}=4\) mg/L.
Both profiles have \(T_{>K}=2\) hours. Their AUCs are \(AUC_{0,6}=(4)(2)=8\) mg·h/L for Profile A and \(AUC_{0,6}=(8)(2)=16\) mg·h/L for Profile B.
For Profile A, \(I(4)=4/(4+4)=0.5000\), giving \(J_{0,6}=(0.5000)(2)=1.000\) inhibition-hours. For Profile B, \(I(8)=8/(4+8)=0.6667\), giving \(J_{0,6}=(0.6667)(2)=1.333\) inhibition-hours. A pure threshold-duration hypothesis predicts the same duration above threshold for both, but a hypothesis in which inhibition depth also contributes predicts greater integrated inhibition for Profile B.
Selecting a Metric and Checking Its Fit
A disciplined selection starts with a response pattern and a mechanism, then asks what feature of concentration should predict that pattern. The following sequence helps keep that reasoning explicit.
Use the concentration relevant to the target and state the integration interval. Confirm that profiles being compared use the same units, analyte, and window.
Decide whether the proposed driver is peak concentration, total exposure, time above a meaningful threshold, or accumulated fractional inhibition. Give a biological rationale for \(K\) or for the chosen inhibition function.
Use \(C_{\max}\), integrate \(C(t)\) for AUC, count time above \(K\), or integrate \(I(C(t))\) for \(J_{0,T}\). If concentrations are sampled, integration requires an explicit interpolation rule; sparse sampling can miss peaks or threshold crossings.
Compare the predicted ordering across profiles with the observed response pattern, while considering variability and other determinants of response. A mismatch can challenge the proposed metric or its assumptions; it does not by itself identify the correct alternative.
For sampled concentration data, a common AUC approximation between adjacent observations is the trapezoidal rule: the area over an interval of length \(\Delta t\) is approximately \((C_i+C_{i+1})\Delta t/2\). For time above a threshold, simply counting sample points above \(K\) is not generally a valid duration estimate. If a segment is assumed linear between points on opposite sides of \(K\), estimate the crossing time by linear interpolation. The interpolation assumption and sampling density should be reported when they materially affect the result.
A selected metric is most credible when the exposure is measured in the pharmacologically relevant compartment, the response timescale is compatible with the metric, and the model’s concentration-response assumptions are plausible. For instance, using a peak sampled too infrequently may underestimate \(C_{\max}\), and a threshold borrowed from an assay may not represent a meaningful in vivo threshold. A changing biological response that cannot be explained by the contemporaneous concentration-inhibition relation is a reason to question the instantaneous-equilibrium assumption, rather than to treat any one summary metric as automatically sufficient.
Comparisons, Limitations, and Common Pitfalls
| Metric | What it retains | Potentially relevant pattern | Important limitation |
|---|---|---|---|
| \(C_{\max}\) | Highest concentration in the interval | Acute peak-driven effect | Ignores how long concentrations remain elevated |
| AUC | Total concentration-time exposure | Response related to overall exposure under a justified model | Does not represent the concentration-response nonlinearity by itself |
| \(T_{>K}\) | Duration above a specified threshold | Threshold-duration mechanism | Depends strongly on the validity of \(K\) and discards concentration differences above it |
| \(J_{0,T}\) | Accumulated fractional inhibition under a specified \(I(C)\) | Response related to both inhibition depth and duration | Depends on the inhibition model and does not automatically represent downstream response or clinical benefit |
These summaries can be useful alternatives, but they are not interchangeable. AUC is often more stable than a peak estimate when sampling is sparse, but stability alone does not make it mechanistically appropriate. Threshold time can be easy to interpret, but profiles just below and just above \(K\) are treated differently even if their biological effects are nearly equal. Integrated inhibition preserves inhibition depth, yet it still compresses the time course into one number and can omit recovery, adaptation, target turnover, or downstream delays.
Common mistake: “The two regimens have equal AUC, so they must produce equal pharmacological effects.” This reasoning assumes that the response is determined by AUC in a way that makes profiles with equal area equivalent. That is not generally true: the examples show equal AUC with different peaks, threshold durations, and integrated inhibition. The correction is to state the mechanism and response pattern first, calculate the corresponding metric, and treat competing metrics as alternatives to evaluate rather than as interchangeable measures.
A further limitation is that target inhibition is not necessarily the functional response. The conversion from target inhibition to a pathway biomarker or clinical endpoint may be nonlinear, delayed, or buffered by target reserve. Thus \(J_{0,T}\) can summarize target-level pharmacology without predicting the same ordering or magnitude for a downstream outcome. An exposure metric is a choice about the exposure feature to summarize, not a substitute for specifying how that feature affects the response.
Check Your Understanding
Answer each question, then compare your reasoning with the solutions below.
- A rapid response is hypothesized to increase monotonically with instantaneous target-site concentration. Which of the four metrics is the most direct candidate, and what important profile feature does it omit?
- A constant concentration of 3 mg/L is maintained for 4 hours. Under \(I(C)=C/(3+C)\), calculate time-integrated inhibition.
- Compare 1 mg/L for 6 hours with 6 mg/L for 1 hour. Both profiles have the same AUC. If \(IC_{50}=2\) mg/L and \(K=1.5\) mg/L, calculate \(J\) and \(T_{>K}\) for each.
- Why can counting sampled observations above \(K\) give a misleading estimate of time above threshold?
Solutions. 1. \(C_{\max}\) is the most direct candidate for an acute response that depends on the highest instantaneous concentration. It omits duration and total exposure, so it cannot distinguish profiles with the same peak but different concentration-time courses. 2. The fractional inhibition is \(I(3)=3/(3+3)=0.5\). Therefore \(J=(0.5)(4\text{ h})=2.000\) inhibition-hours. 3. Both AUCs are \((1)(6)=(6)(1)=6\) mg·h/L. For the first profile, \(I(1)=1/(2+1)=0.3333\), so \(J=(0.3333)(6)=2.000\) inhibition-hours; it never exceeds 1.5 mg/L, so \(T_{>K}=0\) hours. For the second, \(I(6)=6/(2+6)=0.7500\), so \(J=(0.7500)(1)=0.7500\) inhibition-hours; it exceeds 1.5 mg/L for 1 hour, so \(T_{>K}=1\) hour. 4. Sample points do not reveal exactly when a concentration crosses the threshold between observations, and sparse sampling may miss a brief crossing or peak. Estimating duration requires an explicit assumption about the concentration curve between samples, such as linear interpolation, and adequate sampling for the question.